Location History:
- AZ Landgraaf, NL (2000)
- Landgraat, NL (2000)
- Landgraaf, NL (2000 - 2004)
Company Filing History:
Years Active: 2000-2004
Title: Cobus De Roos: Innovator in Cardiac Pacing Technology
Introduction
Cobus De Roos is a prominent inventor based in Landgraaf, Netherlands. He has made significant contributions to the field of cardiac pacing technology, holding a total of 9 patents. His work focuses on optimizing cardiac output and improving heart condition through innovative pacing systems.
Latest Patents
One of his latest patents is a four-chamber pacing system designed for optimizing cardiac output and determining heart condition. This pacing system provides multiple chamber pacing of a patient's heart, specifically programmed for the treatment of various forms of heart failure. The system utilizes impedance sensing to determine optimum pacing parameters, particularly for pacing the left ventricle to maximize left heart output. Additionally, impedance sensing is employed to detect arrhythmias and monitor the progression of heart failure. The invention includes obtaining impedance measurements to determine the timing of right heart valve closure and right ventricular contractions, allowing for optimal synchronization of left ventricular pacing with right ventricular contractions. This innovative approach ensures bi-ventricular mechanical synchronization, adjusted for maximum cardiac output.
Career Highlights
Cobus De Roos is associated with Medtronic, Inc., a leading company in medical technology. His work at Medtronic has been instrumental in advancing cardiac pacing systems and improving patient outcomes.
Collaborations
He has collaborated with notable coworkers, including Arnoldus P Bakels and Robert Leinders, contributing to the development of cutting-edge technologies in the field of cardiology.
Conclusion
Cobus De Roos is a key figure in the innovation of cardiac pacing technology, with a focus on enhancing heart function and patient care. His contributions through patents and collaborations continue to shape the future of cardiac treatment.